Skip to main content

Arcus Biosciences, Inc.

RCUS
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001724521

In the last 90 days, Arcus Biosciences, Inc. insiders filed 0 open-market purchases and 2 sales; 231 institutions reported holding it in 13F filings for Q2 2026, worth $3.78B in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Arcus Biosciences, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of RCUS: Q4 2024 compared with Q1 2025
MeasureQ4 2024Of which not filed for Q1 2025Q1 2025Change
Holders1861187+2
Shares83.9M131.9K97.2M+13.4M (+16.0%)
Value$1.25B$1.96M$763.3M−$484.3M (−38.8%)

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (32)

Institutions that held Arcus Biosciences, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to RCUS in Q1 2025
InstitutionSharesValue% of portfolio
Ra Capital Management, L.P.1,136,364$8.92M0.15%
Wellington Management Group LLP1,082,808$8.50M0.00%
Sofinnova Investments, Inc.1,037,776$8.15M0.61%
Cutter Capital Management, LP731,818$5.74M2.50%
Campbell & CO Investment Adviser LLC165,474$1.30M0.10%
Fisher Asset Management, LLC137,638$1.08M0.00%
Nuveen, LLC131,859$1.04M0.00%
Marshall Wace, LLP112,051$879.6K0.00%
SummitTX Capital, L.P.110,890$870.5K0.04%
Mangrove Partners83,997$659.4K0.07%
Squarepoint Ops LLC75,711$594.3K0.00%
D. E. Shaw & Co., Inc.56,041$439.9K0.00%
Walleye Capital LLC54,582$428.5K0.00%
Virginia Retirement Systems Et Al44,000$345.4K0.00%
Y-Intercept (Hong Kong) Ltd31,414$246.6K0.02%
Capula Management Ltd29,053$228.1K0.00%
Oxford Asset Management LLP22,420$176.0K0.08%
Universal- Beteiligungs- und Servicegesellschaft mbH17,631$138.4K0.00%
Fox Run Management, L.L.C.16,985$133.3K0.02%
Bayesian Capital Management, LP14,200$111.5K0.02%
Graham Capital Management, L.P.13,025$102.2K0.00%
CIBC World Markets Corp12,065$94.7K0.00%
Knott David M Jr12,000$94.2K0.04%
Bank of Montreal10,899$85.6K0.00%
E Fund Management Co., Ltd.10,498$82.4K0.00%
Pictet Asset Management Holding SA10,452$82.0K0.00%
Virtus Investment Advisers, Inc.9,572$75.1K0.02%
True Wealth Design, LLC126$9900.00%
Assetmark, Inc43$3380.00%
Lindbrook Capital, LLC13$1020.00%
Bessemer Group Inc34$00.00%
Hantz Financial Services, Inc.11$00.00%

Sold out (30)

Institutions that held Arcus Biosciences, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Not filed for Q1 2025 yet (1)

Institutions that held Arcus Biosciences, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RCUS in Q4 2024 that haven't filed for Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Nuveen Asset Management, LLC131,859$1.96M